Post-Transplantation Consolidation With Pembrolizumab Feasible in Patients With PTCL
Researchers sought to determine whether post-transplantation consolidation with pembrolizumab would be an option for patients with PTCL.
Diagnosis & Disease Information
Additional FDA Request Delays Decision on Reformulated Denileukin Diftitox
Denileukin diftitox is an engineered IL-2-diphtheria toxin fusion protein.
AFM13 Shows Clinical Efficacy in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
Researchers sought to determine whether AFM13 monotherapy would yield clinical activity in patients with relapsed/refractory peripheral T-cell lymphoma.
Golidocitinib Yields Durable Antitumor Responses in Relapsed/Refractory PTCL
Researchers sought to determine whether golidocitinib would have antitumor response in patients with relapsed or refractory PTCL.
Consolidative Stem Cell Transplant May Improve Outcomes Among Patients With PTCL
Researchers sought to determine whether patients with PTCL who have a complete response after A+CHP would benefit from SCT.
Validation of a New Prognostic Tool in Aggressive Large B-Cell Lymphoma
Researchers sought to validate a new prognostic tool for patients with aggressive large B-cell lymphoma.
CCR7 Alterations May Indicate Poor Prognosis in ATL Treated With Mogamulizumab Without HSCT
Researchers sought to determine whether CCR7 alterations are associated with survival outcomes in patients with adult T-cell leukemia/lymphoma treated with mogamulizumab without HSCT.
Cutaneous T-Cell Lymphoma Incidence on the Rise in the United States
The incidence of cutaneous T-cell lymphoma in the United States increased from 2000 to 2018, with an annual percent change of 0.61%.
PLM60 Plus Pegaspargase Shows Promise in Extranodal Natural Killer and T-Cell Lymphoma
Researchers sought to determine whether PLM60 with pegaspargase would have efficacy in patients with extranodal natural killer/T-cell lymphoma.
Novel Transcriptomic Subclassification Approach for PTCL Developed
Researchers sought to develop a gene expression-based subclassification for improved PTCL diagnosis.
- Loading...
Loading...
Loading... 
Loading...